Transforming growth factor β1 in the human endometrium. Cyclic variation, increased expression by estradiol and progesterone, and regulation of plasminogen activators and plasminogen activator inhibitor-1

Biology of Reproduction

Volumn 58, Issue 6, 1998, Pages 1343-1350

  Casslén, Bertil ^a   Sandberg, Tove ^a   Gustavsson, Barbro ^a   Willén, Roger ^a   Nilbert, Mef ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE RECEPTOR; ESTRADIOL; MESSENGER RNA; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; PROGESTERONE; TRANSFORMING GROWTH FACTOR BETA1; UROKINASE;

ADULT; ARTICLE; AUTORADIOGRAPHY; CONTROLLED STUDY; ENDOMETRIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; IMMUNOCYTOCHEMISTRY; MENSTRUAL CYCLE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY;

EID: 0031837098     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod58.6.1343     Document Type: Article

References (51)

1. Danø K, Behrendt N, Brünner N, Ellis V, Ploug M, Pyke C. The urokinase receptor. Protein structure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8:189-203.
2. Loskutoff D. Regulation of PAI-1 gene expression. Fibrinolysis 1991; 5:197-206.
3. Blasi F, Conese M, Möller LB. The urokinase receptor: structure, regulation and inhibitor-mediated internalization. Fibrinolysis 1994; 8: 182-188.
4. Strickland DK, Kounnas MZ, Williams SE, Argraves WS. LDL receptor-related protein (LRP): a multiligand receptor. Fibrinolysis 1994; 8:204-215.
5. Massagué J. The transforming growth factor-β family. Annu Rev Cell Biol 1990; 6:597-641.
6. Roberts AB, Sporn MB. The transforming growth factor-βs. In: Roberts AB, Sporn MB. (eds.), Peptide Growth Factors and Their Receptors I. Berlin: Springer Verlag; 1990: 419-472.
7. Croxtall J, Jamil A, Ayub M, Colletta A, While J. TGF-β stimulation of endometrial and breast-cancer cell growth. Int J Cancer 1992; 50: 822-827.
8. Andreasen P, Georg B, Lund L, Riccio A, Stacey S. Plasminogen activator inhibitors: hormonally regulated serpins. Mol Cell Endocrinol 1990; 68:1-19.
9. Odekon LE, Blasi F, Rifkin DB. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β. J Cell Physiol 1994; 158:398-407.
10. Kauma S, Matt D, Strom S, Eierman D, Turner T. Interleukin-1β, human leukocyte antigen HLA-DRa, and transforming growth factor-β expression in endometrium, placenta, and placental membranes. Am J Obstet Gynecol 1990; 163:1430-1437.
11. Murphy LJ, Gong Y, Murphy LC. Growth factors in normal and malignant uterine tissue. Ann NY Acad Sci 1991; 622:383-401.
12. 125]TGF β1-binding sites. Endocrinology 1994; 135:439-449.
13. Gold LI, Saxena B, Mittal KR. Increased expression of transforming growth factor β isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium - evidence for paracrine and autocrine action. Cancer Res 1994; 54:2347-2358.
14. Marshburn PB, Arici AM, Casey ML. Expression of transforming growth factor-β1 messenger ribonucleic acid and the modulation of deoxyribonucleic acid synthesis by transforming growth factor-β 1 in human endometrial cells. Am J Obstet Gynecol 1994; 170:1152-1158.
15. Bruner KL, Rodgers WH, Gold LI, Korc M, Hargrove JT, Matrisian LM, Osteen KG. Transforming growth factor β mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci USA 1995; 92: 7362-7366.
16. Tang XM, Zhao Y, Rossi MJ, Aburustum RS, Ksander GA, Chegini N. Expression of transforming growth factor-β (TGFβ) isoforms and TGFβ type II receptor messenger ribonucleic acid and protein, and the effect of TGFβs on endometrial stromal cell growth and protein degradation in vitro. Endocrinology 1994; 135:450-459.
17. Arici A, Macdonald PC, Casey ML. Modulation of the levels of transforming growth factor β messenger ribonucleic acids in human endometrial stromal cells. Biol Reprod 1996; 54:463-469.
18. Dumont N, O'Connor-McCourt MD, Philip A. Transforming growth factor-β receptors on human endometrial cells: identification of the type I, II, and III receptors and glycosylphosphatidylinositol anchored TGF-β binding proteins. Mol Cell Endocrinol 1995; 111:57-66.
19. Casslén B, Åstedt B. Fibrinolytic activity of human uterine fluid. Acta Obstet Gynecol Scand 1981; 60:55-58.
20. Casslén B, Thorell J, Åstedt B. Effect of IUD on urokinase-like immunoreactivity and plasminogen activators in human uterine fluid. Contraception 1981; 23:435-446.
21. Casslén B, Åstedt B. Occurrence of both urokinase and tissue plasminogen activator in the human endometrium. Contraception 1983; 28:553-564.
22. Casslén B, Urano S, Ny T. Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells. Thromb Res 1992; 66:75-87.
23. Casslén B, Nordengren J, Gustavsson B, Nilbert M, Lund LR. Progesterone stimulates degradation of urokinase plasminogen activator (u-PA) in endometrial stromal cells by increasing its inhibitor (PAI-1) and surface expression of the u-PA receptor. J Clin Endocrinol & Metab 1995; 80:2776-2784.
24. Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril 1950; 1:3-25.
25. Casslén B, Siler-Khodr T, Harper M. Progesterone regulation of prolactin release from human endometrial stromal cells in culture: potential bioassay for progestational activity. Acta Endocrinol 1990; 122: 137-144.
26. Casslén B, Urano S, Lecander I, Ny T. Plasminogen activators in the human endometrium, cellular origin and hormonal regulation. Blood Coagul Fibrinolysis 1992; 3:133-138.
27. Casslén B, Gustavsson B. Expression of cell membrane receptors for urokinase plasminogen activator (uPA) in the human endometrium increases during the ovarian cycle. Fibrinolysis 1991; 5:243-248.
28. 125I to high specific activity. Biochim Biophys Acta 1971; 251:363-369.
29. Thomas PS. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 1980; 77:5201-5205.
30. Feinberg AP, Vogelstein B. A technique for radiolabelling DNA restriction fragments to high specific activity. Anal Biochem 1984; 137; 266-267.
31. Ny T, Sawdey M, Lawrence D, Millan J, Loskutoff D. Cloning and sequence of a cDNA coding for the human β-migrating endothelial-cell-type plasminogen activator inhibitor. Proc Natl Acad Sci USA 1986; 83:6776-6780.
32. + RNA. Proc Natl Acad Sci USA 1984; 81:4727-4731.
33. Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Danø K, Apella E, Blasi F. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J 1990; 9:467-474.
34. Pennica D, Holmes WE, Kohr WJ, Harkins WN, Vehar GA, Ward CA, Bennet WF, Yelverton E, Seeburg PH, Heynecker HL, Goeddel DV Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 1983; 301:214.
35. Schatz F, Lockwood CJ. Progestin regulation of plasminogen activator inhibitor type-1 in primary cultures of endometrial stromal and decidual cells. J Clin Endocrinol & Metab 1993; 77:621-625.
36. Sandberg T, Eriksson P, Gustavsson B, Casslén B. Differential regulation of the plasminogen activator inhibitor-1 (PAI-1) gene expression by growth factors and progesterone in endometrial stromal cells. Mol Human Reprod 1997; 3:781-787.
37. Laiho M, Keski-Oja J. Growth factors in the regulation of pericellular proteolysis: a review. Cancer Res 1989; 49:2533-2553.
38. Casey ML, Mibe M, Macdonald PC. Regulation of parathyroid hormone-related protein gene expression in human endometrial stromal cells in culture. J Clin Endocrinol & Metab 1993; 77:188-194.
39. Moser TL, Enghild JJ, Pizzo SV, Stack MS. The extracellular matrix proteins laminin and fibronectin contain binding domains for human plasminogen and tissue plasminogen activator. J Biol Chem 1993; 268:18917-18923.
40. Farrar J, Carson D. Differential temporal and spatial expression of mRNA encoding extracellular matrix components in decidua during the peri-implantation period. Biol Reprod 1992; 46:1095-1108.
41. Zhu H, Huang J, Mazela J, Elias J, Tseng L. Progestin stimulates the biosynthesis of fibronectin and accumulation of fibronectin mRNA in human endometrial stromal cells. Hum Reprod 1992; 7:141-146.
42. Keski-Oja J, Raghow R, Sawdey M, Loskutoff DJ, Postlethwaite AE, Kang AH, Moses HL. Regulation of mRNAs for type-1 plasminogen activator inhibitor, fibronectin, and type I procollagen by transforming growth factor-β. J Biol Chem 1988; 263:3111-3115.
43. Wikner N, Elder J, Persichitte K, Mink P, Clark R. Transforming growth factor-β modulates plasminogen activator activity and plasminogen activator inhibitor type-1 expression in human keratinocytes in vitro. J Invest Dermatol 1990; 95:607-613.
44. Allan E, Zeheb R, Gelehrter T, Heaton J, Fukumoto S. Transforming growth factor β inhibits plasminogen activator (PA) activity and stimulates production of urokinase-type PA, PA inhibitor-1 mRNA, and protein in rat osteoblast-like cells. J Cell Physiol 1991; 149:34-43.
45. 2 production, in human synovial fibroblasts. Proc Natl Acad Sci USA 1991; 88:7180-7184.
46. Lund L, Römer J, Rønne E. Urokinase-receptor biosynthesis, mRNA level and gene transcription are increased by transforming growth factor β1 in human A549 lung carcinoma cells. EMBO J 1991; 10:3399-3407.
47. Saksela O, Rifkin DB. Release of basic fibroblast growth factor-henaran sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol 1990; 110:767-775.
48. Rybo G. Plasminogen activators in the endometrium. Acta Obstet Gynecol Scand 1966; 45:97-118.
49. Phillips GD, Whitehead RA, Stone AM, Ruebel MW, Goodkin ML, Knighton DR. Transforming growth factor-β (TGF-β) stimulation of angiogenesis - an electron microscopic study. J Submicrosc Cytol Pathol 1993; 25:149-155.
50. Yamamoto T, Terada N, Nishizawa Y, Petrow V. Angiostatic activities of medroxyprogesterone acetate and its analogues. Int J Cancer 1994; 56:393-399.
51. Peek M, Markham R, Fraser I. The effects of natural and synthetic sex steroids on human decidual endothelial cell proliferation. Hum Reprod 1995; 10:2238-2243.